NCT02584933 2026-02-03
Roll-over Study to Allow Access to Certinib (LDK378) for Patients Who Are on Ceritinib Treatment in a Novartis-sponsored Study
Novartis
Phase 4 Active not recruiting
Novartis
University of Florida
Brigham and Women's Hospital
Murdoch Childrens Research Institute
Centre Hospitalier Régional d'Orléans